MX9203643A - Derivados imidociclicos y procedimiento para su preparacion. - Google Patents
Derivados imidociclicos y procedimiento para su preparacion.Info
- Publication number
- MX9203643A MX9203643A MX9203643A MX9203643A MX9203643A MX 9203643 A MX9203643 A MX 9203643A MX 9203643 A MX9203643 A MX 9203643A MX 9203643 A MX9203643 A MX 9203643A MX 9203643 A MX9203643 A MX 9203643A
- Authority
- MX
- Mexico
- Prior art keywords
- imidociclicos
- derivatives
- procedure
- preparation
- tissue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Estos compuestos inhiben las metaloproteasas implicadas en la degradacióndel tejido. Los compuestos de la invención pueden formularse parautilizarse en una variedad de estados que implican la degradación deltejido.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919113930A GB9113930D0 (en) | 1991-06-27 | 1991-06-27 | Chemical compounds |
GB919113844A GB9113844D0 (en) | 1991-06-27 | 1991-06-27 | Chemical compounds |
GB929209402A GB9209402D0 (en) | 1992-04-30 | 1992-04-30 | Chemical compounds |
GB929210343A GB9210343D0 (en) | 1992-05-14 | 1992-05-14 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9203643A true MX9203643A (es) | 1995-01-31 |
Family
ID=27450705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9203643A MX9203643A (es) | 1991-06-27 | 1992-06-26 | Derivados imidociclicos y procedimiento para su preparacion. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5252560A (es) |
EP (1) | EP0520573A1 (es) |
JP (1) | JPH0625284A (es) |
KR (1) | KR930000481A (es) |
AU (1) | AU1864092A (es) |
CA (1) | CA2072551A1 (es) |
FI (1) | FI922964A (es) |
IE (1) | IE922083A1 (es) |
MX (1) | MX9203643A (es) |
NO (1) | NO922530L (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530161A (en) * | 1991-07-08 | 1996-06-25 | British Bio-Technology Limited | Hydroxamic acid based collagenase inhibitors |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
AUPM627594A0 (en) * | 1994-06-16 | 1994-07-07 | Willis, Gregory Lynn Dr | Animal bedding material |
WO1996033733A1 (fr) * | 1995-04-25 | 1996-10-31 | Fuji Yakuhin Kogyo Kabushiki Kaisha | Nouveau remede pour affections cutanees |
GB9613547D0 (en) * | 1996-06-27 | 1996-08-28 | Pharmacia Spa | Matrix metalloproteinase inhibitors |
US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
US6861441B1 (en) | 1999-08-10 | 2005-03-01 | Smithkline Beecham Corporation | Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer |
EP1294699B1 (en) | 2000-05-12 | 2016-04-13 | Genzyme Corporation | Modulators of tnf- alpha signalling |
WO2003063891A1 (en) * | 2002-01-29 | 2003-08-07 | Wyeth | Compositions and methods for modulating connexin hemichannels |
US20040157804A1 (en) * | 2002-10-16 | 2004-08-12 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
ES2315922T3 (es) * | 2004-04-14 | 2009-04-01 | Gilead Sciences, Inc. | Analogos de fosfonato de compuestos inhibidores de la integrasa del vih. |
AU2015210833B2 (en) | 2014-02-03 | 2019-01-03 | Vitae Pharmaceuticals, Llc | Dihydropyrrolopyridine inhibitors of ROR-gamma |
CN104130144A (zh) * | 2014-07-30 | 2014-11-05 | 新疆农垦科学院 | 酞酸酯类塑化剂通用半抗原、抗原的合成方法及应用 |
CA2963140A1 (en) | 2014-10-14 | 2016-04-21 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ror-gamma |
US9663515B2 (en) | 2014-11-05 | 2017-05-30 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
US9845308B2 (en) | 2014-11-05 | 2017-12-19 | Vitae Pharmaceuticals, Inc. | Isoindoline inhibitors of ROR-gamma |
EP3331876B1 (en) | 2015-08-05 | 2020-10-07 | Vitae Pharmaceuticals, LLC | Modulators of ror-gamma |
EP3868750A1 (en) | 2015-11-20 | 2021-08-25 | Vitae Pharmaceuticals, LLC | Modulators of ror-gamma |
TWI757266B (zh) | 2016-01-29 | 2022-03-11 | 美商維它藥物有限責任公司 | ROR-γ調節劑 |
US9481674B1 (en) | 2016-06-10 | 2016-11-01 | Vitae Pharmaceuticals, Inc. | Dihydropyrrolopyridine inhibitors of ROR-gamma |
WO2019023207A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF RORƳ |
WO2019018975A1 (en) | 2017-07-24 | 2019-01-31 | Vitae Pharmaceuticals, Inc. | INHIBITORS OF ROR GAMMA |
KR20230158005A (ko) | 2021-03-18 | 2023-11-17 | 씨젠 인크. | 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2025996A1 (de) * | 1970-05-27 | 1971-12-09 | Chemie Grünenthal GmbH, 5190 Stolberg | Abkömmlinge von Mercaptocarbonsäuren |
GB8311286D0 (en) * | 1983-04-26 | 1983-06-02 | Searle & Co | Carboxyalkyl peptide derivatives |
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
ZW23187A1 (en) * | 1986-12-15 | 1988-06-29 | Hoffmann La Roche | Phosphinic acid derivatives |
GB8726714D0 (en) * | 1987-11-14 | 1987-12-16 | Beecham Group Plc | Compounds |
EP0369391A3 (en) * | 1988-11-15 | 1991-09-25 | Boehringer Ingelheim Pharmaceuticals Inc. | N-substituted amides |
EP0401963A1 (en) * | 1989-04-13 | 1990-12-12 | Beecham Group p.l.c. | Phosphonopeptides with collagenase inhibiting activity |
GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
WO1991005555A2 (en) * | 1989-10-13 | 1991-05-02 | The Salk Institute Biotechnology/Industrial Associates, Inc. | N-acyl peptide metalloendopeptidase inhibitors and methods of using same |
WO1991005763A1 (en) * | 1989-10-13 | 1991-05-02 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Dipeptide-analog-based metalloendopeptidase inhibitors and methods of using same |
CA2045621A1 (en) * | 1989-11-24 | 1991-05-25 | Akira Okuyama | Physiologically active substance be-16627 |
GB9008065D0 (en) * | 1990-04-10 | 1990-06-06 | Beecham Group Plc | Novel compounds |
GB9008078D0 (en) * | 1990-04-10 | 1990-06-06 | Beecham Group Plc | Novel compounds |
EP1069137A1 (en) * | 1990-09-24 | 2001-01-17 | W.R. Grace & Co.-Conn. | Peptides having thrombospondin-like activity and their therapeutic use |
EP0489577B1 (en) * | 1990-12-03 | 1995-03-22 | Celltech Limited | Peptidyl derivatives |
-
1992
- 1992-06-23 EP EP92201844A patent/EP0520573A1/en not_active Withdrawn
- 1992-06-26 CA CA002072551A patent/CA2072551A1/en not_active Abandoned
- 1992-06-26 MX MX9203643A patent/MX9203643A/es unknown
- 1992-06-26 JP JP4193215A patent/JPH0625284A/ja active Pending
- 1992-06-26 AU AU18640/92A patent/AU1864092A/en not_active Abandoned
- 1992-06-26 FI FI922964A patent/FI922964A/fi not_active Application Discontinuation
- 1992-06-26 NO NO92922530A patent/NO922530L/no unknown
- 1992-06-26 KR KR1019920011209A patent/KR930000481A/ko not_active Application Discontinuation
- 1992-06-29 US US07/905,933 patent/US5252560A/en not_active Expired - Fee Related
- 1992-07-01 IE IE208392A patent/IE922083A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1864092A (en) | 1993-01-07 |
KR930000481A (ko) | 1993-01-15 |
US5252560A (en) | 1993-10-12 |
NO922530L (no) | 1992-12-28 |
FI922964A (fi) | 1992-12-28 |
CA2072551A1 (en) | 1992-12-28 |
FI922964A0 (fi) | 1992-06-26 |
IE922083A1 (en) | 1992-12-30 |
EP0520573A1 (en) | 1992-12-30 |
JPH0625284A (ja) | 1994-02-01 |
NO922530D0 (no) | 1992-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9203643A (es) | Derivados imidociclicos y procedimiento para su preparacion. | |
MX9205768A (es) | Derivados de 3-fenilpirazoles, procedimiento para su preparacion y composicion fungicida que los contiene | |
GT199900102A (es) | Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen. | |
MX9203027A (es) | Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen. | |
MX9205432A (es) | Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene. | |
ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9101530A (es) | Polifluorohidrocarburos lineales saturados,procedimiento para su produccion y composicion limpiadora que los contiene | |
MX9202290A (es) | Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion. | |
PA8521701A1 (es) | Derivados de pirazol | |
MX9302944A (es) | Compuestos en n-yodopropargil-hidantoina, sus composiciones y su preparacion y empleo como agentes antimicrobianos. | |
PA8506301A1 (es) | Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida | |
MX9207383A (es) | Derivados de 2-imidazolin-5-onas y 2-imidazolin-5-tionas, procedimiento para su preparacion y composiciones fungicidas que los contienen. | |
MX9204563A (es) | Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende. | |
MX9202152A (es) | Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
IT1252567B (it) | Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
ES2054746T3 (es) | Aditivo para piensos estabilizado y procedimiento para su preparacion. | |
MX9201642A (es) | Derivados de amidino fenil alanina, procedimiento para su preparacion, su empleo y agentes que los contienen. | |
MX9201652A (es) | Derivados de benc imidazolio, procedimiento para su preparacion y composiciones herbicidas que los contienen. | |
MX9204395A (es) | Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
AR240802A1 (es) | Derivados de 3-fenil-4-cianopirrol, procedimiento para su preparacion y composiciones microbicidas que los contienen | |
ES2186989T3 (es) | Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion. | |
ITRM960867A0 (it) | Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fat tore nf-kb | |
AR240018A1 (es) | Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol. | |
MX9102499A (es) | Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene. |